Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer

被引:16
|
作者
Shunichi Tsujitani
Kenji Fukuda
Nobuaki Kaibara
机构
[1] Tottori University,Department of Surgery, Division of Surgical Oncology, School of Medicine
关键词
S-1; Cisplatin; Combination chemotherapy; Advanced gastric carcinoma;
D O I
10.1007/s10120-003-0223-x
中图分类号
学科分类号
摘要
引用
收藏
页码:50 / 57
页数:7
相关论文
共 50 条
  • [31] S-1/CDDP/Lentinan combination chemotherapy for inoperable advanced gastric cancer
    Nagahashi, S
    Suzuki, H
    Hibi, T
    PROCEEDINGS OF THE 6TH INTERNATIONAL GASTRIC CANCER CONGRESS, 2005, : 155 - 161
  • [32] Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor
    Yuehong Cui
    Qian Li
    Yiyi Yu
    Yong Chen
    Yi Feng
    Yan Wang
    Tianshu Liu
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 145 - 152
  • [33] Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor
    Cui, Yuehong
    Li, Qian
    Yu, Yiyi
    Chen, Yong
    Feng, Yi
    Wang, Yan
    Liu, Tianshu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 145 - 152
  • [34] A feasibility study of outpatient chemotherapy with S-1 + cisplatin in patients with advanced gastric cancer
    Shunsuke Okazaki
    Takako E. Nakajima
    Jun Hashimoto
    Seiichiro Yamamoto
    Daisuke Takahari
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Yasuhiro Shimada
    Kenji Tamura
    Gastric Cancer, 2013, 16 : 41 - 47
  • [35] Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer
    Yoshitaka Honma
    Yasuhiro Shimada
    Atsuo Takashima
    Satoru Iwasa
    Ken Kato
    Tetsuya Hamaguchi
    Yasuhide Yamada
    Hirokazu Taniguchi
    Shigeki Sekine
    Ryoji Kushima
    International Journal of Clinical Oncology, 2014, 19 : 863 - 870
  • [36] Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer
    Hiroaki Mieno
    Keishi Yamashita
    Kei Hosoda
    Hiromitsu Moriya
    Katsuhiko Higuchi
    Mizutomo Azuma
    Shouko Komori
    Tsutomu Yoshida
    Satoshi Tanabe
    Wasaburo Koizumi
    Natsuya Katada
    Masahiko Watanabe
    Surgery Today, 2017, 47 : 1249 - 1258
  • [37] Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
    Jin Young Kim
    Young Rok Do
    Keon Uk Park
    Jong Gwang Kim
    Yee Soo Chae
    Min Kyoung Kim
    Kyung Hee Lee
    Hun Mo Ryoo
    Sung Hwa Bae
    Jin Ho Baek
    Hong Suk Song
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 527 - 532
  • [38] Efficacy of S-1 plus cisplatin combination chemotherapy in patients with HER2-positive advanced gastric cancer
    Honma, Yoshitaka
    Shimada, Yasuhiro
    Takashima, Atsuo
    Iwasa, Satoru
    Kato, Ken
    Hamaguchi, Tetsuya
    Yamada, Yasuhide
    Taniguchi, Hirokazu
    Sekine, Shigeki
    Kushima, Ryoji
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (05) : 863 - 870
  • [39] Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer
    Mieno, Hiroaki
    Yamashita, Keishi
    Hosoda, Kei
    Moriya, Hiromitsu
    Higuchi, Katsuhiko
    Azuma, Mizutomo
    Komori, Shouko
    Yoshida, Tsutomu
    Tanabe, Satoshi
    Koizumi, Wasaburo
    Katada, Natsuya
    Watanabe, Masahiko
    SURGERY TODAY, 2017, 47 (10) : 1249 - 1258
  • [40] Multicenter phase II trial of S-1, paclitaxel and cisplatin triplet combination chemotherapy in patients with advanced gastric cancer
    Kim, Jin Young
    Do, Young Rok
    Park, Keon Uk
    Kim, Jong Gwang
    Chae, Yee Soo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Ryoo, Hun Mo
    Bae, Sung Hwa
    Baek, Jin Ho
    Song, Hong Suk
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 527 - 532